Parenteral Drugs (India) Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 46.552 million compared to INR 73.611 million a year ago. Net loss was INR 336.744 million compared to INR 283.139 million a year ago. Basic loss per share was INR 11.31 compared to INR 9.5 a year ago. For the half year, total revenue was INR 75.859 million compared to INR 160.901 million a year ago. Net loss was INR 658.929 million compared to INR 560 million a year ago. Basic loss per share was INR 22.14 compared to INR 18.79 a year ago.